Interrogation of the TCGA showed PADI1 and/or PADI3 expression in several solid tumours, bladder, pancreatic, cervical, head and neck and clear cell renal cancers with known hypoxic character. This evidence concerns the gene PADI3 and clear cell renal carcinoma.